NEW YORK, Feb. 18 (GenomeWeb News) - Cepheid reported higher revenues as well as losses for the fourth quarter of 2003 yesterday.
The company's revenues for the quarter totaled $5.3 million, up from $4.7 million during the same period last year.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.